![]() |
市场调查报告书
商品编码
1616720
山奈酚市场机会、成长动力、产业趋势分析及 2024 年至 2032 年预测Kaempferol Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
2023年,全球山奈酚市场估值为62亿美元,预计2024年至2032年复合年增长率为3.3%。抗发炎解决方案。在全球范围内,由于山奈酚具有抗氧化、抗发炎、细胞保护和抗癌特性,製药业在药物中广泛使用山奈酚。人们对山奈酚的健康益处及其在各行业的多样化应用的认识不断提高,正在推动该行业的成长。山奈酚是多种水果和蔬菜中天然存在的黄酮类化合物,因其强大的抗氧化、抗发炎和抗癌特性而闻名。
整个产业分为纯度、应用和地区。预计2023 年将达到60 亿美元的里程碑,98% 纯度的市场将实现显着增长,2024 年至2032 年复合年增长率将继续保持3.3%。成长。预计到2023 年,山奈酚市场的医药应用领域将达到32 亿美元,将蓬勃发展,2024 年至2032 年的复合年增长率将维持在3.3%。优势的日益认可。其强大的抗氧化、抗发炎和抗癌特性使山奈酚成为针对多种疾病(包括心血管疾病、糖尿病和特定癌症类型)开发新药和治疗方法的主要成分。价值到 2023 年,销售额将达到 16 亿美元。
市场范围 | |
---|---|
开始年份 | 2023年 |
预测年份 | 2024-2032 |
起始值 | 62 亿美元 |
预测值 | 83亿美元 |
复合年增长率 | 3.3% |
The Global Kaempferol Market was valued at USD 6.2 billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2032. The market growth is likely to be driven by the rising need for various pharmaceutical products, encompassing medicines, skincare items, and anti-inflammatory solutions. Globally, the pharmaceutical sector extensively utilizes kaempferol in medicines, thanks to its antioxidant, anti-inflammatory, cytoprotective, and anti-cancer properties. Heightened awareness of kaempferol's health benefits and its diverse applications across industries are propelling the industry growth. Kaempferol, a naturally occurring flavonoid in numerous fruits and vegetables, is celebrated for its robust antioxidant, anti-inflammatory, and anti-cancer properties.
The overall industry is segmented into purity, application, and region. Projected to achieve a milestone of USD 6 billion in 2023, the 98% purity segment of the market is set for notable growth, continuing at a CAGR of 3.3% from 2024 to 2032. This surge is largely due to the rising demand for high-purity kaempferol in the pharmaceutical and nutraceutical sectors, where its valued properties shine. Forecasted to reach USD 3.2 billion by 2023, the pharmaceutical application segment of the kaempferol market is set for vigorous growth, maintaining a CAGR of 3.3% from 2024 to 2032. The segment growth is fueled by the growing acknowledgment of kaempferol's therapeutic advantages. Its potent antioxidant, anti-inflammatory, and anti-cancer traits position kaempferol as a prime ingredient in crafting new drugs and treatments for diverse conditions, spanning cardiovascular diseases, diabetes, and specific cancer types.Asia Pacific kaempferol market is projected to reach a value of USD 1.6 billion in 2023. This anticipated growth is largely attributed to the rising consumer awareness regarding the health benefits of kaempferol, notably its antioxidant, anti-inflammatory, and anti-cancer attributes.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $6.2 Billion |
Forecast Value | $8.3 Billion |
CAGR | 3.3% |